drugset / Trial / NCT04139330
NPC-06 to Acute Pain in Herpes Zoster
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this trial is to investigate the efficiency of pain relief and the safety of NPC-06 for the acute pain in herpes zoster in the placebo-controlled double-blind parallel group trial, in addition to explore the effective concentration of NPC-06.
Timeline
- Start
- 2019-11-21
- Primary completion
- 2021-02-28
- Completion
- 2021-02-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fosphenytoin | Small molecule | 12 mg/kg | Intravenous |
| Subject | Fosphenytoin | Small molecule | 18 mg/kg | Intravenous |